StreetAlpha.app
Home › Stocks › FLGT

Fulgent Genetics, Inc. (FLGT)

$24.21
▲ +0.56%
LAST CLOSE · NOV 17

Fulgent Genetics provides genetic and diagnostic lab testing for healthcare providers and patients, and develops cancer drug candidates. It last closed at $24.21 on Nov 17, up 0.56% on the day.

AI Auto Pilots
Is FLGT in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$330.3M
+4.7% vs a year ago
Net income
−$90.9M
−27.5% margin
Free cash flow
−$1.4M
−0.4% margin
Gross margin
33.8%
$111.7M gross profit
Valuation
Market cap
$676.4M
27.9M shares
P/E
–
Price to sales
2.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$86.8M
At Sep 30
Debt
$1.5M
At Sep 30
Shareholder equity
$990.5M
Buybacks
$64.1M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $992.6M$992.6MFY2021FY2022: $619.0M$619.0MFY2022FY2023: $289.2M$289.2MFY2023FY2024: $283.5M$283.5MFY2024FY2025: $322.7M$322.7MFY2025

From FLGT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Hold
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Hold
1firm
0 Buy1 Hold0 Sell
Only 1 firm rated FLGT in the past 90 days, not enough for a consensus
Average 12-month target
$25.00
▲ 3.3% upside

Based on 1 analyst who set a price target on FLGT in the past 90 days. The average target is $25.00, with a high of $25.00 and a low of $25.00, compared with the last close of $24.21.

Low $25.00Avg $25.00High $25.00
Blue marker: last close $24.21
Highest target$25.00
Average target$25.00
Lowest target$25.00
Latest rating changes
Piper SandlerTarget raised
Nov 10Hold$19 → $25
Piper SandlerMaintained
Aug 4Hold$19
DateFirmActionRatingPrice target
Nov 10Piper SandlerTarget raisedHold$19 → $25
Aug 4Piper SandlerMaintainedHold$19
Loading…

Technical Analysis

FLGT · as of the Nov 17 close · updated after every close
Uptrend

The stock is 9% above its 20 day and 11% above its 50 day average. It is 21% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 60). The nearest support is the Pivot at $23.96, and the nearest resistance the Pivot R1 at $24.48.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 5.1%/day
Key levels
$31.0452 week high+28.2%
$27.41Swing high (Nov 10)+13.2%
$24.48Pivot R1+1.1%
$24.21Last close
$23.96Pivot−1.0%
$23.68Pivot S1−2.2%
$22.0620 day average−8.9%
$21.5550 day average−11.0%
$21.01Swing low (Sep 21)−13.2%
$20.62100 day average−14.8%
$19.11200 day average−21.1%
$13.4652 week low−44.4%
Indicators
RSI (14)59.51Middle of its rangeNeutral
MACD1.07Above its signal lineBullish
Stochastic65.5Middle of its rangeNeutral
ADX (14)23.9Weak trend
Williams %R-35.7Oversold below −80, overbought above −20Neutral
CCI (20)60.0Oversold below −100, overbought above 100Neutral
Rate of change+25.0%Change over 10 sessionsBullish
ATR (14)$1.24Typical daily range, 5.1% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for FLGT

What happened before

See how FLGT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow FLGT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How FLGT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2016.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in FLGT in the last 90 days.

Loading…

See today’s whale options flow across the market →

FLGT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ●62 buying vs 63 selling
  • ▼Held by funds -1.9 pts
  • ●Funds holding +0
  • ▼Superinvestors: 0 added, 3 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1421420.0%
In funds' top 10220.0%
Held by funds54.3%56.2%−1.9 pts
New / increased16 / 4620 / 40+3.3%
Reduced / sold out46 / 1755 / 37−31.5%
Put/call ratio0.00––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See FLGT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FLGT is in one of them and how their past FLGT trades turned out.

FLGT in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered FLGT in an article yet. Here's the latest on the wider market.

About Fulgent Genetics

Fulgent Genetics is a laboratory services company based in El Monte, California. It offers genetic testing, diagnostic testing, anatomic pathology services, and physician interpretation of lab results. Its customers include insurers, hospitals, medical institutions, pharmaceutical and biotech companies, and patients who pay directly for tests. The company is also developing cancer drug candidates that use a nanoencapsulation platform.

Headquarters
El Monte, CA
Founded
2011